source
- CVS Caremark settles FTC antitrust case, agreeing to favor lowest-cost insulin on formulariesCVS Caremark announced a settlement with the Federal Trade Commission that resolves the agency’s antitrust lawsuit alleging the PBM favored higher-priced insulin versions. Under the agreement, Car…
- 340B Drug Discount Program sales hit $100 billion in 2025, up 22.8% year over yearThe Health Resources and Services Administration reported that purchases under the 340B discount program reached $100 billion in 2025, a 22.8% rise from 2024. Expensive medicines made up a growing…